Sabinsa Names Brandon Prenger as Director of Business Development

Sabinsa, a global health science company specializing in sustainable, natural, and well-researched ingredients, has appointed Brandon Prenger as its new Director of Business Development.¹ The strategic hire comes as the company seeks to further accelerate its expansion and strengthen brand partnerships within the United States market.

What Background Does Brandon Prenger Bring to Commercial Channels?

Prenger joins Sabinsa with more than 20 years of experience in the dietary supplement and nutraceutical ingredients sector. His professional background spans multiple commercial channels, including direct sales, retail, and multi-level marketing (MLM). Throughout his career, Prenger has specialized in strategic business planning, territory expansion, competitive product positioning, new business prospecting, and product commercialization.

From a product development perspective, Prenger’s expertise aligns with several core health and wellness categories. His previous work covers cognitive health, joint support, sports nutrition and performance, immune health, and digestive wellness.

According to Sabinsa, this breadth of experience will offer significant support for its cusomters. "Brandon’s extensive industry experience across diverse market channels and health categories gives him a unique ability to help our customers identify innovative solutions from Sabinsa’s broad portfolio of science-backed ingredients," stated Shaheen Majeed, Global CEO and Managing Director of Sabinsa, noting that the appointment coincides with the company's ongoing efforts to scale its U.S. presence.

What Is Prenger’s Prior History in Ingredient Commercialization?

Before his appointment at Sabinsa, Prenger held various business development positions at several notable industry firms, including INS/Innovative Natural Solutions, SpecNova, Nutragenesis/Innophos Nutrition, Deerland Enzymes, and National Enzyme Company. In these previous roles, his responsibilities included building sales territories and cultivating strategic relationships directly with research and development and product development teams to bring clinically supported branded ingredients to market.

Prenger holds a Bachelor of Science in Animal Science from Southern Illinois University, where he also played as a varsity quarterback. His professional training includes development programs in business acumen, fact-based selling, and time management through Franklin Covey, alongside receiving multiple Purina sales and innovation awards. Prenger is based in Rogersville, Missouri.

How Does This Appointment Support B2B Product Development?

For supplement developers, the addition to Sabinsa's business development leadership interfaces with a substantial manufacturing and R&D infrastructure. Founded in 1988 by the late Dr. Muhammed Majeed, Sabinsa currently manufactures and supplies standardized herbal extracts, nutraceutical and cosmeceutical ingredients, probiotics, minerals, enzymes, and specialty fine chemicals.

The company currently markets more than 120 standardized botanical extracts and employs over 1,800 people globally across 27 manufacturing, research and development, sales, and distribution facilities located in India and the U.S. Its portfolio includes numerous patented, Kosher, and Halal-certified ingredients supported by published clinical studies, backed by a botanical cultivation program encompassing nearly 20,000 acres to secure sustainable, fair-trade raw materials.

This infrastructure directly supports the commercialization of Sabinsa's highly specialized, technically advanced portfolio. A primary example is the company's tetrahydrocurcuminoids ingredient Curcumin C3 Reduct, which recently achieved a positive novel food opinion in Great Britain to match its existing European Union validity and United States self-affirmed GRAS status.² This cross-border regulatory alignment offers an advantage for Prenger’s business development objectives. Because Curcumin C3 Reduct resolves traditional formulation challenges regarding curcumin’s color and bioavailability, it serves as an asset that can be immediately leveraged.

Commenting on his new role, Prenger emphasized the utility of the company's assets for B2B customers: "Their unique branded ingredient portfolio will help customers create successful products that meet evolving consumer needs."

References

1. Sabinsa. Sabinsa Announces Brandon Prenger as Director of Business Development. June 22, 2026. Accessed June 22, 2026. Press release provided via email.
2. Saraceno N. Sabinsa's Tetrahydrocurcuminoids Ingredient Receives Great Britain Novel Food Positive Opinion. June 9, 2026. Accessed June 22, 2026. https://www.nutritionaloutlook.com/view/sabinsa-tetrahydrocurcuminoids-ingredient-receives-great-britain-novel-food-positive-opinion